Get the Stockscreener App
15.00
5.49%
0.78
After Hours:
15.00
Gh Research Plc stock is traded at $15.00, with a volume of 552.38K.
It is up +5.49% in the last 24 hours and up +19.14% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$14.22
Open:
$14.32
24h Volume:
552.38K
Relative Volume:
1.96
Market Cap:
$780.42M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-18.99
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
+10.38%
1M Performance:
+19.14%
6M Performance:
+47.64%
1Y Performance:
+63.93%
1-Day Range:
$14.16
$15.31
1-Week Range:
$12.45
$15.31
52-Week Range:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
15.00 | 839.88M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
GH Research PLC stock chart pattern explainedJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
Live market analysis of GH Research PLCJuly 2025 Price Swings & AI Powered Market Trend Analysis - newser.com
Understanding GH Research PLC’s price movementJuly 2025 Review & Weekly Watchlist for Consistent Profits - newser.com
Is GH Research PLC stock dividend yield sustainableMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Will GH Research PLC stock deliver long term returnsJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com
What’s next for GH Research PLC stock price2025 Price Action Summary & AI Based Trade Execution Alerts - newser.com
Historical volatility pattern of GH Research PLC visualizedJuly 2025 Action & Daily Volume Surge Signals - newser.com
What data driven models say about GH Research PLC’s futureRate Hike & Consistent Income Trade Ideas - newser.com
Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - sharewise.com
Is GH Research PLC stock attractive for income investors2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Why GH Research PLC (1KA) stock remains stableShare Buyback & Precise Trade Entry Recommendations - newser.com
Is GH Research PLC stock oversold or undervaluedTrade Risk Report & Daily Profit Maximizing Tips - newser.com
HC Wainwright & Co. Maintains GH Research (GHRS) Buy Recommendation - Nasdaq
GHRS: HC Wainwright Adjusts Price Target to $35, Maintains Buy R - GuruFocus
Is GH Research PLC stock a safe buy before earningsJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
Has GH Research PLC formed a bullish divergencePortfolio Value Summary & Weekly Chart Analysis and Trade Guides - newser.com
Can GH Research PLC (1KA) stock deliver consistent EPS growthTrade Exit Summary & Reliable Price Breakout Alerts - newser.com
Why GH Research PLC stock is favored by pension fundsJuly 2025 Highlights & Real-Time Volume Analysis - newser.com
Visual analytics tools that track GH Research PLC performanceWeekly Trend Report & AI Enhanced Trading Alerts - newser.com
Combining machine learning predictions for GH Research PLCJuly 2025 Snapshot & Safe Capital Allocation Plans - newser.com
GH Research to Engage at Stifel 2025 Healthcare Conference - TipRanks
[6-K] GH Research PLC Current Report (Foreign Issuer) | GHRS SEC FilingForm 6-K - Stock Titan
GH Research PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Behavioral Patterns of GHRS and Institutional Flows - news.stocktradersdaily.com
GH Research Reports Q3 2025 Financial Results - TipRanks
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates - The Manila Times
Measuring GH Research PLC’s beta against major indices2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - newser.com
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):